These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7494608)

  • 21. [Osteodystrophy in children with chronic renal insufficiency in dialysis therapy].
    Bartolozzi G; Pela I; Lavoratti GC; Bettucci E; Sirovich A; Pierattelli M; Materassi M
    Pediatr Med Chir; 1982; 4(1-2):65-9. PubMed ID: 6287442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: a cross-sectional study.
    Coen G; Mazzaferro S; Ballanti P; Sardella D; Chicca S; Manni M; Bonucci E; Taggi F
    Nephrol Dial Transplant; 1996 May; 11(5):813-9. PubMed ID: 8671900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal osteodystrophy.
    Hruska KA
    Baillieres Clin Endocrinol Metab; 1997 Apr; 11(1):165-94. PubMed ID: 9222491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic problems relating to azotaemic osteodystrophy.
    Chan YL; Posen S
    Ann Acad Med Singap; 1982 Jan; 11(1):69-76. PubMed ID: 7073232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal osteodystrophy.
    Haas M
    Wien Med Wochenschr; 2004; 154(5-6):107-18. PubMed ID: 15106893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adynamic bone disease in patients with uremia.
    Fournier A; Yverneau PH; Hué P; Said S; Hamdini N; Eldin HM; Mohageb S; Oprisiu R; Marie A; Solal ME
    Curr Opin Nephrol Hypertens; 1994 Jul; 3(4):396-410. PubMed ID: 8076143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [K/DOQI clinical practice guidelines for management of renal osteodystrophy in predialysis patients].
    Okada N; Tsubakihara Y
    Clin Calcium; 2004 May; 14(5):698-706. PubMed ID: 15577030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperphosphatemia: pharmacologic intervention yesterday, today and tomorrow.
    Malluche HH; Monier-Faugère MC
    Clin Nephrol; 2000 Oct; 54(4):309-17. PubMed ID: 11076107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal osteodystrophy.
    McCarthy JT; Kumar R
    Endocrinol Metab Clin North Am; 1990 Mar; 19(1):65-93. PubMed ID: 2192869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The aplastic form of renal osteodystrophy.
    Sherrard DJ; Hercz G; Pei Y; Segre G
    Nephrol Dial Transplant; 1996; 11 Suppl 3():29-31. PubMed ID: 8840308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment.
    Joy MS; Karagiannis PC; Peyerl FW
    J Manag Care Pharm; 2007 Jun; 13(5):397-411. PubMed ID: 17605511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The importance of bone health in end-stage renal disease: out of the frying pan, into the fire?
    Malluche HH; Mawad H; Monier-Faugere MC
    Nephrol Dial Transplant; 2004 Mar; 19 Suppl 1():i9-13. PubMed ID: 15126648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal osteodystrophy in developing countries.
    Afifi A
    Artif Organs; 2002 Sep; 26(9):767-9. PubMed ID: 12197931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of metabolic acidosis in the pathogenesis of renal osteodystrophy.
    Kraut JA
    Adv Ren Replace Ther; 1995 Jan; 2(1):40-51. PubMed ID: 7614335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteomalacia and Renal Osteodystrophy.
    Modest JM; Sheth H; Gohh R; Aaron RK
    R I Med J (2013); 2022 Oct; 105(8):22-27. PubMed ID: 36173905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of renal osteodystrophy in children.
    Tasic V
    Turk J Pediatr; 2005; 47 Suppl():13-8. PubMed ID: 15884662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adynamic bone disease: from bone to vessels in chronic kidney disease.
    Bover J; Ureña P; Brandenburg V; Goldsmith D; Ruiz C; DaSilva I; Bosch RJ
    Semin Nephrol; 2014 Nov; 34(6):626-40. PubMed ID: 25498381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prevention and treatment of renal osteodystrophy: present and future].
    Fernández E; Craver L
    Nefrologia; 2006; 26 Suppl 3():19-27. PubMed ID: 17469423
    [No Abstract]   [Full Text] [Related]  

  • 39. Role of parathyroid hormone and therapy with active vitamin D sterols in renal osteodystrophy.
    Hernandez JD; Wesseling K; Salusky IB
    Semin Dial; 2005; 18(4):290-5. PubMed ID: 16076350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of treatment of renal osteodystrophy on bone histology.
    Malluche HH; Mawad H; Monier-Faugere MC
    Clin J Am Soc Nephrol; 2008 Nov; 3 Suppl 3(Suppl 3):S157-63. PubMed ID: 18988701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.